Tumor-infiltrating CD8+ T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited-stage small cell esophageal carcinoma.
Zhihui ZhangChaoqi ZhangGuochao ZhangYuejun LuoLiyan XueQingpeng ZengPeng WuLide WangNan SunJie HePublished in: Clinical and translational medicine (2022)